Evolution Wealth Advisors LLC Purchases 1,203 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Evolution Wealth Advisors LLC raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.3% during the first quarter, Holdings Channel reports. The fund owned 29,484 shares of the exchange traded fund’s stock after acquiring an additional 1,203 shares during the period. Evolution Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $2,798,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. State of Michigan Retirement System purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth about $4,744,000. Compass Ion Advisors LLC grew its stake in SPDR S&P Biotech ETF by 13.0% during the 1st quarter. Compass Ion Advisors LLC now owns 3,832 shares of the exchange traded fund’s stock worth $364,000 after buying an additional 441 shares during the last quarter. Breakwater Capital Group purchased a new position in SPDR S&P Biotech ETF during the 1st quarter worth $210,000. Arlington Financial Advisors LLC grew its stake in SPDR S&P Biotech ETF by 201.4% during the 1st quarter. Arlington Financial Advisors LLC now owns 41,783 shares of the exchange traded fund’s stock worth $3,965,000 after buying an additional 27,920 shares during the last quarter. Finally, Fiduciary Alliance LLC grew its stake in SPDR S&P Biotech ETF by 8.4% during the 1st quarter. Fiduciary Alliance LLC now owns 23,033 shares of the exchange traded fund’s stock valued at $2,162,000 after purchasing an additional 1,789 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.5 %

Shares of XBI stock traded down $0.49 on Wednesday, hitting $90.87. The company had a trading volume of 4,671,912 shares, compared to its average volume of 10,621,430. The firm has a market cap of $6.93 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The company has a 50-day moving average price of $90.27 and a 200-day moving average price of $90.94.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.